Quality of life in end-stage renal disease patients during recombinant human erythropoietin therapy. The Canadian Erythropoietin Study Group
- PMID: 2040199
Quality of life in end-stage renal disease patients during recombinant human erythropoietin therapy. The Canadian Erythropoietin Study Group
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical